Terumo Blood and Cell Technologies (BCT) announced that it plans to expand its offerings to Latin America.
The company plans to help bring automated manufacturing to cell and gene therapy companies in Brazil, Colombia and Mexico. With a focus on automation, it makes products that collect, process and separate blood and cells. The company also offers automated manufacturing platforms that support cell and gene therapy (CGT) developers.
Currently, the company has seven offices across Latin America. It has a footprint in Argentina, Uruguay, Brazil, Colombia, Mexico, Peru and Chile, plus a major manufacturing facility in Costa Rica.
Terumo BCT’s products support cell and gene therapy manufacturers throughout the development lifecycle. Technologies being introduced in Latin America include the QuantumFlex cell expansion system, Finia fill and finish system and the company’s portfolio of welders and sealers for therapy manufacturers.
“Across the cell and gene therapy sector, Terumo BCT is supporting the adoption of automation to help CGT companies scale their manufacturing,” said Eduardo Morato, Country Manager of Brazil, Terumo BCT. “Our ambition is that more patients will have access to these life-saving therapies because automated manufacturing helps streamline the process — leading to lower costs and the ability to manufacture more therapies.”
Tell Us What You Think!